Company / Return on Assets (ROA)
RAPT Therapeutics, Inc. Return on Assets (ROA) History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-54.0%
FY2024
5-year range
-67.4% / -31.5%
FY2020-FY2024
Trend
+19.8%
vs FY2023
Sector context
#185 of 213
Health Care
What the data says
RAPT Therapeutics, Inc.'s return on assets (roa) of -54.0% is lower than 87% of companies in the Health Care sector (FY2024). Declined from -31.5% to -54.0% over the past 2 years.
Based on SEC 10-K filings.
-54.0% in FY2024 with a 5-year CAGR of -3.2%.
Declined from -31.5% to -54.0% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -19.2pp
- 5-Year Change
- -3.2pp
- 10-Year Change
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 213This company -54.0% Sector average -24.1%
▼
-123.8% below sector average
Key checks
Key Insights
- In FY2024, return on assets (roa) increased 19.8% year-over-year.
- Currently 29.9pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2022.
- Lowest return on assets (roa) in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.38 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -54.0% | +19.8% |
| FY2023 | -67.4% | -114.0% |
| FY2022 | -31.5% | +9.6% |
| FY2021 | -34.8% | +21.6% |
| FY2020 | -44.5% | +12.5% |
| FY2019 | -50.8% | +2.1% |
| FY2018 | -51.9% | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026